| NWJFX | VITAX | NWJFX / VITAX | |
| Total Expense Ratio | 0.42 | 0.09 | 467% |
| Annual Report Gross Expense Ratio | 0.42 | 0.09 | 467% |
| Fund Existence | 17 years | 22 years | - |
| Gain YTD | 4.819 | -2.314 | -208% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 50000 | 100000 | 50% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 706M | 131B | 1% |
| Annual Yield % from dividends | 0.47 | 0.41 | 115% |
| Returns for 1 year | 16.93 | 21.25 | 80% |
| Returns for 3 years | 28.16 | 101.54 | 28% |
| Returns for 5 years | 3.87 | 98.89 | 4% |
| Returns for 10 years | 165.66 | 664.46 | 25% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FNDE | 39.02 | 0.20 | +0.52% |
| Schwab Fundamental Emerging MarketsEqETF | |||
| BBAGF | 55.01 | N/A | N/A |
| BB Biotech AG | |||
| BKIV | 39.93 | N/A | N/A |
| BNY Mellon ETF Trust BNY Mellon Innovators ETF | |||
| BNDI | 47.43 | -0.03 | -0.06% |
| NEOS Enhanced Income Aggregate Bond ETF | |||
| PMAR | 45.28 | -0.09 | -0.20% |
| Innovator U.S. Equity Power BffrETF™-Mar | |||